Activation-dependent Expression of Low Affinity IgG Receptors Fc Gamma RII(CD32) and Fc Gamma RIII(CD16) in Subpopulations of Human T Lymphocytes
Overview
Authors
Affiliations
Receptors for IgG (Fc gamma R) are expressed by small subpopulations of peripheral blood T lymphocytes. Our studies demonstrate that T lymphocytes can be induced in vitro to express two different low-affinity Fc gamma R. Mitogen activation of peripheral blood T lymphocytes obtained from eight healthy individuals leads to considerable augmentation of the Fc gamma RIII+ (CD32) T cell subpopulation. The highest percentage of CD32 expressing T lymphocytes could be detected after three days of activation. The T cell subpopulation which transiently express the CD32 antigen, encompasses CD4+ and CD8+ cells. Molecular cloning of the CD32 antigen by reverse transcription and polymerase chain reaction demonstrates that activated human T lymphocytes express the Fc gamma RIIIb2 isoform. The percentage of the Fc gamma RIII+ (CD16) T cell subpopulation was significantly increased only in the lymphocyte populations obtained from three out of eight volunteers immediately after mitogen activation. However, during short-term cell culture the CD16 expressing CD8+ T cell subset increased in the T cell population from all individuals investigated. During this time, the IL-2 receptor alpha-chain (CD25) expression level decreased as a function of time. In contrast to the CD8+CD16+ T cells, the percentage of the non-MCH-restricted CD56+CD16+ T cells was not influenced by mitogen activation and time of cell cultivation. We could show that CD16 in T cells is able to mediate a stimulus leading to proliferation of the CD8+CD56-CD16+ T cells but not that of the CD56+CD16+ T cell subset. This discrepancy cannot be explained by the expression of different Fc gamma RIII isoforms, because both T cell subsets express Fc gamma RIIIA alpha, as we demonstrate in this report.
Astorga-Gamaza A, Grau-Exposito J, Burgos J, Navarro J, Curran A, Planas B Elife. 2022; 11.
PMID: 35616530 PMC: 9177146. DOI: 10.7554/eLife.78294.
Carpenter S, Lu L Front Immunol. 2022; 13:830482.
PMID: 35371092 PMC: 8968866. DOI: 10.3389/fimmu.2022.830482.
Holgado M, Raiden S, Sananez I, Seery V, De Lillo L, Maldonado L Front Cell Infect Microbiol. 2021; 10:607348.
PMID: 33392111 PMC: 7775358. DOI: 10.3389/fcimb.2020.607348.
CD32 is enriched on CD4dimCD8bright T cells.
Virdi A, Wallace J, Barbian H, Richards M, Ritz E, Sha B PLoS One. 2020; 15(9):e0239157.
PMID: 32960910 PMC: 7508398. DOI: 10.1371/journal.pone.0239157.
Harnessing the immune system via FcγR function in immune therapy: a pathway to next-gen mAbs.
Chenoweth A, Wines B, Anania J, Hogarth P Immunol Cell Biol. 2020; 98(4):287-304.
PMID: 32157732 PMC: 7228307. DOI: 10.1111/imcb.12326.